Research HighlightsResearch

Neurology Update: Adjunctive cenobamate for uncontrolled focal epilepsy in adults: phase II trial results

June 12, 2020

A double-blind, randomised, placebo-controlled phase II study of adjunctive cenobamate in adults with uncontrolled focal epilepsy showed high rates of total seizure-freedom over 12 weeks.

Read full update here.

You may also like

Neurological Predictors of Clinical Outcomes in Hospitalized Patients With COVID-19

December 2, 2020

A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the European Academy of Neurology

February 3, 2021

The importance of having a Scientific Panel on Higher Cortical Functions at EAN

March 8, 2019

Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study

December 2, 2020

European Journal of Neurology – Editor-in-Chief – call for applications

February 12, 2019

Biological significance of anti–SARS-CoV-2 antibodies: Lessons learned from progressive multifocal leukoencephalopathy

January 5, 2021

Neurology Update: Sleep-Wake-Disorders

April 2, 2019

Scientific Committee Snap Shot – Dafin Fior Muresanu

June 3, 2019

2nd EAN Science School, 18-20 March 2023

July 20, 2022

Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology

September 1, 2020

Leave a Comment